Silver Book Fact

Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.

Bearse M, Adams A, Han Y, Schneck M, et al. A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy. Prog Retin Eye Res. 2006; 25(5): 425-448. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773701/

Reference

Title
A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy
Publication
Prog Retin Eye Res
Publication Date
2006
Authors
Bearse M, Adams A, Han Y, Schneck M, et al
Volume & Issue
Volume 25, Issue 5
Pages
425-448
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.  
  • A study on the impact of diet on age-related macular degeneration (AMD) found that those who took the highest amounts of carotenoids, such as lutein and zeaxanthin, had a 43%…  
  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.